Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, Intercept Pharmaceuticals, Extended Stay America

Roka Bioscience Inc ROKA -52%; The company announced downbeat third quarter results Thursday; Bank of America downgraded the stock.

Salix Pharmaceuticals, Ltd. SLXP -32% - Late Thursday the company announced a negative accounting revision; Following the announcement analysts at multiple firms downgraded the stock and lowered the price target.

Intercept Pharmaceuticals Inc ICPT -31% - The company reported downbeat financial results; Leerink downgraded the stock; announced results from the FLINT trial evaluating obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis (NASH) were published today in The Lancet.

Financial Engines Inc FNGN -22% - Shares are trending lower following downbeat financial results and a CEO change.

Extended Stay America Inc STAY -20% - The company announced financial results Friday morning, missing top and bottom line estimates.